partial relief
Recently Published Documents


TOTAL DOCUMENTS

29
(FIVE YEARS 8)

H-INDEX

8
(FIVE YEARS 0)

2021 ◽  
Vol 11 (10) ◽  
pp. 109-117
Author(s):  
Shweta Sindagi ◽  
Savita Sajjan ◽  
Anita Halagatti

Sleshmala yonivyapad is one of the most common and burning problem faced by the women all around the globe. The symptoms are vaginal white discharge, itching, foul smell mild pain in vagina. On the bases of chief complaints and review of the disease the shlesmala yonivyapat is compared with Trichomonas vaginalis. There are many treatments prescribed for this problem but they are not free from side effects and with reoccurrence. Hence selection of an appropriate treatment is very essential. Study design: In the present study, 30 patients fulfilling criteria of sleshmala yonivyapat were selected under single group. Patients were given Patrangadi churna 4gms thrice a day with ushnodaka internally after food for 7 days and Yoniprakshalana with Patrangadi kashaya for 7days. This study was carried out for 21 days. The signs and symptoms were observed before and after treatment and were compared. Subjective parameters: Picchila shweta srava, Dourgandya, Kandu and Alpavedana. Objective parameters: Profuse thick creamy discharge, Red and swollen vulva with evidence of pruritis like scratch marks and wet mount showing Trichomonas vaginalis positive. Result: In the present study total 11 subjects showed complete relief, 17 subjects showed moderate relief and 2 subjects showed partial relief after treatment. And 11 subjects showed complete relief, 7 subjects showed moderate relief, 7 subjects showed partial relief and 5 subjects showed no relief after follow up. The total effect of therapy provided statistically highly significant result (p<0.001) in both subjective and objective parameters. Paired ‘t’ test is applied. Thus the study showed the effectiveness of Patrangadi churna internally as well as Patrangadi kashaya yoniprakshalana in alleviating symptoms of sleshmala yonivyapad. Key words: Sleshmala yonivyapad, Patrangadi yoga, Trichomonas vaginalis.


Significance Crucial to the new framework's success will be the ongoing overhaul of state-owned oil company Sonangol, alongside an oil price recovery, as well as politically contentious fuel subsidy removals. Impacts Dollar-denominated bonds have recovered somewhat from their April slump, offering partial relief amid the government’s debt crisis. Controversies surrounding former Vice-President Manuel Vicente will weaken his influence at Sonangol, bolstering the new CEO's autonomy. The opposition remains divided, but calls are growing for a united front against the ruling party in the 2022 general elections.


2020 ◽  
Author(s):  
Cordula Schippert ◽  
Yvonne Witte ◽  
Janina Bartels ◽  
Guillermo-José Garcia-Rocha ◽  
Matthias Jentschke ◽  
...  

Abstract Background: Endometriosis can be associated with considerable pain and sterility. After surgical excision of moderate or severe endometriosis lesions, the rate of recurrence reaches up to 67%. The objective of this retrospective study was to establish the recurrence and pregnancy rates following surgical resection of stage III/IV endometriosis lesions. Indications for operation were endometriosis symptoms, sonographic findings and/or infertility. Methods : A total of 456 patients who underwent stage III/IV endometriosis surgery between 2004 and 2014 were sent a questionnaire relating to their postoperative medical treatment, pregnancies, relief of symptoms and recurrence. Responses of 206 patients (45.2%) and their clinical data were analysed for this study. Results : A total of 66.5% (N=137) of patients had stage III disease, and 33.5% (N=69) had stage IV disease. The average age was 37 years (17-59). A total of 63.1% (N=130) of surgeries were performed by laparoscopy, 21.8% (N=45) were performed by laparotomy and 15% (N=31) were performed by conversion. Complete resection of endometriosis lesions was achieved in 90.8% of patients (N=187). After surgery, 48.5% (N=100) of the women did not receive hormonal treatment; the main reason was the desire for children in 53%. Complete or partial relief in complaints was achieved in 93.2% (N=192). The rate of recurrence was 21.8% (N=45). The statistically significant factors that was associated with a higher risk to develop recurrence was an age <35 (p<0.005).After surgery, 65.8% (79/120) of patients who wished to have children became pregnant. There was a statistically significant association among a higher postoperative pregnancy rate and age <35 (p<0.003) in multivariante logistic regression analysis and laparoscopic surgical access in univariante logistic regression analysis (p<0.01). Conclusion: We assessed the high percentage of complete or partial relief of symptoms of 93.2%, the high postoperative pregnancy rate of 65.8% and the low rate of recurrence of 21.8% compared to international literature to be very encouraging for women suffering from moderate and severe endometriosis. Though laparoscopy is considered the ´gold standard` of endometriosis surgery, laparotomy still may be indicated in patients with extensive endometriosis especially to preserve reproductive function.


Pedosphere ◽  
2019 ◽  
Vol 29 (6) ◽  
pp. 752-763
Author(s):  
Ahmad RAJABI ◽  
Parviz EHSANZADEH ◽  
Jamshid RAZMJOO

Keyword(s):  

Headline INTERNATIONAL: US move on Huawei offers partial relief


2018 ◽  
Vol 32 (01) ◽  
pp. 048-052 ◽  
Author(s):  
Melissa Aldrich ◽  
Mark Schaverien

AbstractAlthough nonoperative and operative treatments for lymphedema (LE) are well established, these procedures typically provide only partial relief from limb swelling, functional impairment, and the risk of cellulitis. The lack of a cure for LE, however, is due to an incomplete understanding of the underlying pathophysiological mechanisms, and current research efforts are focusing on elucidating these processes to provide new, targeted therapies for this prevalent disease for which there is no cure. This article reviews the current literature regarding the pathophysiological mechanisms that underlie LE, as well as new and emerging therapies for the condition.


Sign in / Sign up

Export Citation Format

Share Document